• 1
    Kohlstaedt LA, Wang J, Friedman JM, Rice PA & Steitz TA (1992) Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 17831790.
  • 2
    Sawaya MR, Prasad R, Wilson SH, Kraut J & Pelletier H (1997) Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry 36, 1120511215.
  • 3
    Rittinger K, Divita G & Goody RS (1995) Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc Natl Acad Sci USA 92, 80468049.
  • 4
    Doublié S, Tabor S, Long AM, Richardson CC & Ellenberger T (1998) Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature 391, 251258.
  • 5
    Mansky LM & Temin HM (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69, 50875094.
  • 6
    Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483489.
  • 7
    Preston BD, Poiesz BJ & Loeb LA (1988) Fidelity of HIV-1 reverse transcriptase. Science 242, 11681171.
  • 8
    Hsieh JC, Zinnen S & Modrich P (1993) Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem 268, 2460724613.
  • 9
    Kati WM, Johnson KA, Jerva LF & Anderson KS (1992) Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem 267, 2598825997.
  • 10
    Joyce CM & Benkovic SJ (2004) DNA polymerase fidelity: kinetics, structure, and checkpoints. Biochemistry 43, 1431714324.
  • 11
    Zinnen S, Hsieh JC & Modrich P (1994) Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase. J Biol Chem 269, 2419524202.
  • 12
    Huang H, Chopra R, Verdine GL & Harrison SC (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669.
  • 13
    Sarafianos SG, Clark AD, Das K, Tuske S, Birktoft JJ, Ilankumaran P, Ramesha AR, Sayer JM, Jerina DM, Boyer PL et al. (2002) Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J 21, 66146624.
  • 14
    Boyer PL, Sarafianos SG, Arnold E & Hughes SH (2001) Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol 75, 48324842.
  • 15
    Roberts JD, Bebenek K & Kunkel TA (1988) The accuracy of reverse transcriptase from HIV-1. Science 242, 11711173.
  • 16
    Yu H & Goodman MF (1992) Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates. J Biol Chem 267, 1088810896.
  • 17
    Perrino FW, Preston BD, Sandell LL & Loeb LA (1989) Extension of mismatched 3′ termini of DNA is a major determinant of the infidelity of human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 86, 83438347.
  • 18
    Shah FS, Curr KA, Hamburgh ME, Parniak M, Mitsuya H, Arnez JG & Prasad VR (2000) Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 275, 2703727044.
  • 19
    Garforth SJ, Kim TW, Parniak MA, Kool ET & Prasad VR (2007) Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the beta3-beta4 hairpin loop in dNTP selection. J Mol Biol 365, 3849.
  • 20
    Tuske S, Sarafianos SG, Clark AD, Ding J, Naeger LK, White KL, Miller MD, Gibbs CS, Boyer PL, Clark P et al. (2004) Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol 11, 469474.
  • 21
    Das K, Bandwar RP, White KL, Feng JY, Sarafianos SG, Tuske S, Tu X, Clark AD, Boyer PL, Hou X et al. (2009) Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem 284, 3509235100.
  • 22
    Das K, Martinez SE, Bauman JD & Arnold E (2012) HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat Struct Mol Biol 19, 253259.
  • 23
    Rubinek T, Bakhanashvili M, Taube R, Avidan O & Hizi A (1997) The fidelity of 3′ misinsertion and mispair extension during DNA synthesis exhibited by two drug-resistant mutants of the reverse transcriptase of human immunodeficiency virus type 1 with Leu74–>Val and Glu89–>Gly. Eur J Biochem 247, 238247.
  • 24
    Matamoros T, Kim B & Menéndez-Arias L (2008) Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis. J Mol Biol 375, 12341248.
  • 25
    Sluis-Cremer N, Arion D, Kaushik N, Lim H & Parniak MA (2000) Mutational analysis of Lys65 of HIV-1 reverse transcriptase. Biochem J 348(Pt 1), 7782.
  • 26
    Garforth SJ, Domaoal RA, Lwatula C, Landau MJ, Meyer AJ, Anderson KS & Prasad VR (2010) K65R and K65A Substitutions in HIV-1 Reverse Transcriptase Enhance Polymerase Fidelity by Decreasing Both dNTP Misinsertion and Mispaired Primer Extension Efficiencies. J Mol Biol 401, 3344.
  • 27
    Kim B, Hathaway TR & Loeb LA (1998) Fidelity of mutant HIV-1 reverse transcriptases: interaction with the single-stranded template influences the accuracy of DNA synthesis. Biochemistry 37, 58315839.
  • 28
    Jacobo-Molina A, Ding J, Nanni RG, Clark AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL & Clark P (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci USA 90, 63206324.
  • 29
    Ding J, Das K, Hsiou Y, Sarafianos SG, Clark AD, Jacobo-Molina A, Tantillo C, Hughes SH & Arnold E (1998) Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J Mol Biol 284, 10951111.
  • 30
    Xiong Y & Eickbush TH (1990) Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J 9, 33533362.
  • 31
    Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J & Shafer RW (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31, 298303.
  • 32
    Shafer RW, Jung DR & Betts BJ (2000) Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries. Nat Med 6, 12901292.
  • 33
    Mendelman LV, Petruska J & Goodman MF (1990) Base mispair extension kinetics. Comparison of DNA polymerase alpha and reverse transcriptase. J Biol Chem 265, 23382346.
  • 34
    Müller B, Restle T, Reinstein J & Goody RS (1991) Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase. Biochemistry 30, 37093715.
  • 35
    Pandey VN, Kaushik N, Rege N, Sarafianos SG, Yadav PN & Modak MJ (1996) Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry 35, 21682179.
  • 36
    Rezende LF, Drosopoulos WC & Prasad VR (1998) The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Res 26, 30663072.
  • 37
    Gutiérrez-Rivas M & Menéndez-Arias L (2001) A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis. Nucleic Acids Res 29, 49634972.
  • 38
    Drosopoulos WC & Prasad VR (1996) Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase. J Virol 70, 48344838.
  • 39
    Margot NA, Isaacson E, McGowan I, Cheng AK, Schooley RT & Miller MD (2002) Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. AIDS 16, 12271235.
  • 40
    Wainberg MA, Miller MD, Quan Y, Salomon H, Mulato AS, Lamy PD, Margot NA, Anton KE & Cherrington JM (1999) In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Antivir Ther 4, 8794.
  • 41
    White KL, Margot NA, Wrin T, Petropoulos CJ, Miller MD & Naeger LK (2002) Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity. Antimicrob Agents Chemother 46, 34373446.
  • 42
    Parikh UM, Koontz DL, Chu CK, Schinazi RF & Mellors JW (2005) In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. Antimicrob Agents Chemother 49, 11391144.
  • 43
    Curr K, Tripathi S, Lennerstrand J, Larder BA & Prasad VR (2006) Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro. J Gen Virol 87, 419428.
  • 44
    Boyer PL, Ferris AL & Hughes SH (1992) Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J Virol 66, 10311039.
  • 45
    Le Grice SF, Cameron CE & Benkovic SJ (1995) Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol 262, 130144.
  • 46
    Götte M, Maier G, Gross HJ & Heumann H (1998) Localization of the active site of HIV-1 reverse transcriptase-associated RNase H domain on a DNA template using site-specific generated hydroxyl radicals. J Biol Chem 273, 1013910146.
  • 47
    Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC & Ferrin TE (2004) UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem 25, 16051612.
  • 48
    Dunbrack RL & Cohen FE (1997) Bayesian statistical analysis of protein side-chain rotamer preferences. Protein Sci 6, 16611681.